HemoAlert® One-Step
IFOB (Immuncological Fecal Occult Blood Test)
Initial colorectal cancer screening
Testing Wavied for Doctors
The future of FOB testing, HemoAlert is the latest
advanced technological breakthrough in
immunological FOBT with higher sensitivity and
specificity.
Better Healthcare
  • Clinically approved immunological FOB test
  • Human hemoglobin specific greatly reduces false positive results
  • Test can be performed at Physicians office, lab or hospitals.
  • High SENSITIVITY and SPECIFICITY
Improved Compliance
  • No dietary or drug restrictions
  • Clear test results in 5 minutes
  • Simple, easy interpretation, safe and non-invasive
  • FDA approved and CLIA waived
  • Nearly 5 times higher reimbursement rate than traditional FOB test
High Specificity
  • Monoclonal antibody
  • Recognizes only human blood
  • Enhances patient compliance
High Sensitivity
  • Detects human blood in stool as low as 0.05ug hHb/ml
  • Safe, odorless, and easy to use
  • Low false positive results
  • More accurate
Hemosure Immonological Fecal Occult Blood Test, Product #ELST1-CK30
CPT code
 Reimbursement
 Use
G0328QW
 USD 22.22
 Screen code use for colorectal cancer screening
82274QW
 USD 22.22
 Diagnostic code use for detection of blood in feces form
whatever cases
"...in comparison with guaiac-based tests...immunochemical tests are more patient-friendly..."

-American Cancer Society Guidelines for the Early Detection of Cancer, 2003
Worldwide Distributors Wanted
Colon Cancer Tests
ElabSupply.com
ElabSupply.com